6B5E | pdb_00006b5e

Mycobacterium tuberculosis RmlA in complex with dTDP-glucose


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.85 Å
  • R-Value Free: 
    0.218 (Depositor), 0.225 (DCC) 
  • R-Value Work: 
    0.171 (Depositor), 0.182 (DCC) 
  • R-Value Observed: 
    0.174 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 6B5E

Ligand Structure Quality Assessment 


This is version 1.2 of the entry. See complete history

Literature

The structure of glucose-1-phosphate thymidylyltransferase from Mycobacterium tuberculosis reveals the location of an essential magnesium ion in the RmlA-type enzymes.

Brown, H.A.Thoden, J.B.Tipton, P.A.Holden, H.M.

(2018) Protein Sci 27: 441-450

  • DOI: https://doi.org/10.1002/pro.3333
  • Primary Citation Related Structures: 
    6B5E, 6B5K

  • PubMed Abstract: 

    Tuberculosis, caused by the bacterium Mycobacterium tuberculosis, continues to be a major threat to populations worldwide. Whereas the disease is treatable, the drug regimen is arduous at best with the use of four antimicrobials over a six-month period. There is clearly a pressing need for the development of new therapeutics. One potential target for structure-based drug design is the enzyme RmlA, a glucose-1-phosphate thymidylyltransferase. This enzyme catalyzes the first step in the biosynthesis of l-rhamnose, which is a deoxysugar critical for the integrity of the bacterium's cell wall. Here, we report the X-ray structures of M. tuberculosis RmlA in complex with either dTTP or dTDP-glucose to 1.6 Å and 1.85 Å resolution, respectively. In the RmlA/dTTP complex, two magnesium ions were observed binding to the nucleotide, both ligated in octahedral coordination spheres. In the RmlA/dTDP-glucose complex, only a single magnesium ion was observed. Importantly, for RmlA-type enzymes with known three-dimensional structures, not one model shows the position of the magnesium ion bound to the nucleotide-linked sugar. As such, this investigation represents the first direct observation of the manner in which a magnesium ion is coordinated to the RmlA product and thus has important ramifications for structure-based drug design. In the past, molecular modeling procedures have been employed to derive a three-dimensional model of the M. tuberculosis RmlA for drug design. The X-ray structures presented herein provide a superior molecular scaffold for such endeavors in the treatment of one of the world's deadliest diseases.


  • Organizational Affiliation
    • Department of Biochemistry, University of Wisconsin, Madison, WI, 53706, USA.

Macromolecule Content 

  • Total Structure Weight: 269.15 kDa 
  • Atom Count: 19,586 
  • Modeled Residue Count: 2,274 
  • Deposited Residue Count: 2,368 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Glucose-1-phosphate thymidylyltransferase
A, B, C, D, E
A, B, C, D, E, F, G, H
296Mycobacterium tuberculosis H37RvMutation(s): 0 
Gene Names: rmlArfbARv0334
EC: 2.7.7.24
UniProt
Find proteins for P9WH13 (Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv))
Explore P9WH13 
Go to UniProtKB:  P9WH13
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP9WH13
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 6 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
DAU

Query on DAU



Download:Ideal Coordinates CCD File
AA [auth E]
CA [auth F]
DA [auth F]
FA [auth G]
I [auth A]
AA [auth E],
CA [auth F],
DA [auth F],
FA [auth G],
I [auth A],
IA [auth H],
N [auth B],
S [auth C],
W [auth D],
Z [auth E]
2'DEOXY-THYMIDINE-5'-DIPHOSPHO-ALPHA-D-GLUCOSE
C16 H26 N2 O16 P2
YSYKRGRSMLTJNL-URARBOGNSA-N
TYD

Query on TYD



Download:Ideal Coordinates CCD File
HA [auth G]
K [auth A]
KA [auth H]
Q [auth B]
U [auth C]
HA [auth G],
K [auth A],
KA [auth H],
Q [auth B],
U [auth C],
Y [auth D]
THYMIDINE-5'-DIPHOSPHATE
C10 H16 N2 O11 P2
UJLXYODCHAELLY-XLPZGREQSA-N
EDO

Query on EDO



Download:Ideal Coordinates CCD File
M [auth A]1,2-ETHANEDIOL
C2 H6 O2
LYCAIKOWRPUZTN-UHFFFAOYSA-N
CL

Query on CL



Download:Ideal Coordinates CCD File
L [auth A]CHLORIDE ION
Cl
VEXZGXHMUGYJMC-UHFFFAOYSA-M
MG

Query on MG



Download:Ideal Coordinates CCD File
BA [auth E]
EA [auth F]
GA [auth G]
J [auth A]
JA [auth H]
BA [auth E],
EA [auth F],
GA [auth G],
J [auth A],
JA [auth H],
O [auth B],
P [auth B],
T [auth C],
X [auth D]
MAGNESIUM ION
Mg
JLVVSXFLKOJNIY-UHFFFAOYSA-N
NA

Query on NA



Download:Ideal Coordinates CCD File
R [auth B],
V [auth C]
SODIUM ION
Na
FKNQFGJONOIPTF-UHFFFAOYSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.85 Å
  • R-Value Free:  0.218 (Depositor), 0.225 (DCC) 
  • R-Value Work:  0.171 (Depositor), 0.182 (DCC) 
  • R-Value Observed: 0.174 (Depositor) 
Space Group: P 21 21 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 72.323α = 90
b = 111.264β = 90
c = 290.363γ = 90
Software Package:
Software NamePurpose
REFMACrefinement
HKL-3000data reduction
HKL-3000data scaling
PHASERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)United StatesGM115921

Revision History  (Full details and data files)

  • Version 1.0: 2018-02-21
    Type: Initial release
  • Version 1.1: 2020-01-01
    Changes: Author supporting evidence
  • Version 1.2: 2023-10-04
    Changes: Data collection, Database references, Derived calculations, Refinement description